Tirzepatide (Zepbound) 4.5.1
The Official Side Effect Profile# According to the MHRA Summary of Product Characteristics, Mounjaro's most common side effects affect your digestive system: Nausea and vomiting - particularly during the first few weeks Diarrhoea or constipation - affecting around 20-30% of patients Abdominal pain - usually mild to moderate Reduced appetite - which is actually part of how the medication works Injection site reactions - redness, swelling, or itching Notably absent from this list
Do not inject into muscle tissue intentionally, as intramuscular injection of semaglutide is not approved and creates significantly faster, less controlled absorption
For CagriSema, studies have found that a weekly combination of cagrilintide and semaglutide leads to significant weight loss
Psychological Shift Fat loss induces mental changes as well
Dosing & Reconstitution Guide Educational guide for reconstitution and intermittent dosing Standard Protocol (2 mL = 2,500 IU/mL) Frequency: Inject 3 times weekly subcutaneously (e.g., Monday/Wednesday/Friday)